US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Brutons Tyrosine Kinase (Btk) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brutons Tyrosine Kinase (Btk) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Global Osteoporosis Drugs Market 2015-2019
5/6/2015 | published by: TechNavio - Infiniti Research Ltd.
... of fracture increases. Osteoporosis primarily affects women, but can also affect men. In women, bone loss occurs rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone ...  |  read more...
USD 2,500
Epithelial Sodium Channel (ENaC) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Epithelial Sodium Channel (ENaC) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
GABAA Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The GABAA Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, GABAA Agonists- ...  |  read more...
USD 1,250
Calming and Sleeping in Saudi Arabia
5/7/2015 | published by: Euromonitor International
... prices of food and housing as well as longer commutes due to overcrowding in most cities were the main contributory factors driving demand for calming and sleeping products in 2014. As a result, the category ...  |  read more...
USD 990
Austria Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... growth expectations remain resiliently subdued over the next few years, which prompted us tomake downward revisions and caused a decline in Risk/Reward Index. Headline Expenditure Projections Pharmaceuticals: EUR4.45bn (USD5.96bn) in 2014 to EUR4.42bn (USD4.86bn) in ...  |  read more...
USD 1,295
C5a Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The C5a Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
GABAA Modulators -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The GABAA Modulators Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, GABAA Modulators- ...  |  read more...
USD 1,250
GABAB Modulators -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The GABAB Modulators Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, GABAB Modulators- ...  |  read more...
USD 1,250
Hemolytic Uremic Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hemolytic Uremic Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Toll-Like Receptor 9 (TLR-9) Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Toll-Like Receptor 9 (TLR-9) Antagonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Global and China Famciclovir Industry
5/1/2015 | published by: QYResearch Group
... industry chain structure. The Famciclovir market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes ...  |  read more...
USD 2,800
Hong Kong Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... increasingly important role in HongKong. This shift also means that patients will increasingly have to shoulder their own health expenses. Headline Expenditure Projections Pharmaceuticals: HKD12.07bn (USD1.56bn) in 2014 to HKD12.96bn (USD1.67bn) in 2015; +7.4% inlocal ...  |  read more...
USD 1,295
Pakistan Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... see scope for an increase inpharmaceutical prices. This will in turn encourage more investment from drugmakers to capture thecommercial opportunities stemming from the country's epidemiological profile. Downside risks remain dueto the lack of policy continuity ...  |  read more...
USD 1,295
Bradykinin Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bradykinin Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Bradykinin Antagonists- ...  |  read more...
USD 1,250
Bradykinin Receptor B1 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bradykinin Receptor B1 Antagonists Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Topoisomerase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Topoisomerase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Topoisomerase Inhibitors- ...  |  read more...
USD 1,250
Angola Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... the price of oil will have a heavy impact the economy as a whole. Despite the dominance of oilrevenue for Angola's state funding, the country will go ahead with its plans to decentralise the healthsystem. ...  |  read more...
USD 1,295
Central America Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... coming years. Despite political instability in some areas of theregion, Central America's medicine consumption will continue to grow in 2015. Headline Expenditure Projections Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +4.1%. Our forecast has ...  |  read more...
USD 1,295
South Korea Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... country's ageing population. This isparticularly as other avenues - including shifting the healthcare cost burden onto consumers - will remainmore subdued as private expenditure already accounts for a large portion of total healthcarespending. Moreover, South ...  |  read more...
USD 1,295
Global and China Ribavirin Industry
5/6/2015 | published by: QYResearch Group
... industry chain structure. The Ribavirin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes ...  |  read more...
USD 2,800
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Broad Spectrum Chemokine Inhibitors (BSCIs) Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Netherlands Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... for curativecare and supplemental benefits is mandatory for the entire population. However, the Act is based on theprinciples of managed competition: insurers and providers of care compete on price and quality while thegovernment has set ...  |  read more...
USD 1,295
C1 Esterase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The C1 Esterase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Trypsin Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Trypsin Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Trypsin Inhibitors- ...  |  read more...
USD 1,250
  2    4  5  6  7  8  9  10